This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Eisenstein EL, Leon MB, Kandzari DE, Edwards R, Cowper PA, Kong DF, Silverstein MD, Mark DB, Anstrom KJ.Economic analysis of ENDEAVOR vs. Cypher stents: results from the ENDEAVOR III Trial. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 152 abstr. PCV60, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com
Eisenstein EL, Edwards R, Cowper PA, Kong DF, Silverstein MD, Mark DB, Anstrom KJ, Wijns W.Economic analysis of the endeavor drug-eluting stent vs. the Driver bare metal stent: results from the ENDEAVOR II Trial. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 152 abstr. PCV59, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com
Rights and permissions
About this article
Cite this article
Zotarolimus-eluting stents ENDEAVOR to be cost effective. Pharmacoecon. Outcomes News 579, 2 (2009). https://doi.org/10.2165/00151234-200905790-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905790-00001